Product & ReviewsAntibodies

HUMAN ANTI RANIBIZUMAB

Product Details

Cat. No.
HCA305
Type
Primary Antibody
Clonality
Monoclonal
Host
Human
Buy Now
Bio-Rad

Receive your quote directly from the manufacturer.

Description

Human Anti-Ranibizumab Antibody, clone AbD16746_hIgG1 is a paratope specific, inhibitory anti-idiotypic antibody in IgG1 format that recognizes the monoclonal antibody drug ranibizumab. The antibody does not recognize recombinant human vascular endothelial growth factor A (VEGF-A) or ranibizumab when in complex with recombinant human VEGF-A.Clone AbD16746_hIgG1 is a fully human recombinant monoclonal antibody with IgG1 isotype and is suitable as a control or calibration standard in an anti-drug antibody (ADA) assay.This antibody also recognizes the monoclonal antibody drug bevacizumab.Ranibizumab (Lucentis) is a humanized Fab fragment antibody (VH3-23/kappa1), originating from the same parental mouse antibody as bevacizumab (Avastin); it has 4 amino acid exchanges in the heavy chain and 1 amino acid exchange in the light chain compared to bevacizumab. Ranibizumab was first approved to treat wet age-related macular degeneration (AMD), a common form of age-related vision loss. It is also approved for the treatment of macular edema following retinal vein occlusion, diabetic macular edema, and diabetic retinopathy. Ranibizumab inhibits angiogenesis by binding to VEGF-A, blocking its interaction with VEGF receptors on the surface of endothelial cells, and thus preventing the subsequent growth of new blood vessels.View a summary of all anti-ranibizumab antibodies

Biological Information

  • Clonality: Monoclonal
  • Host: Human
  • Isotype: IgG1

Handling

  • Quantity: 0.1 mg
  • Storage: +4ºC, -20ºC if preferred
  • Buffer: Phosphate buffered saline, 0.01% Thiomersal

Applications

  • ELISA (ELISA)
Specificity rating
Sensitivity rating
Quality rating
Write your own review

Product Overview

Links